back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-05-03 10:28 Tx date 2021-05-03 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,100
-50,000 vol $0.482 each |
82,960 | |
| Filed 2021-04-30 09:50 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$6,093
+17,410 vol $0.35 each |
17,410 | |
| Filed 2021-04-30 09:49 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-30 09:47 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-5,999
-17,140 vol $0.35 each |
132,960 | |
| Filed 2021-04-30 09:44 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,800
+80,000 vol $0.21 each |
150,100 | |
| Filed 2021-04-30 09:42 Tx date 2021-04-29 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,800
-80,000 vol $0.21 each |
0 | |
| Filed 2020-06-30 13:38 Tx date 2020-06-25 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,800
+80,000 vol $0.21 each |
80,000 | |
| Filed 2020-06-30 11:29 Tx date 2020-06-30 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$16,800
+80,000 vol $0.21 each |
80,000 | |
| Filed 2020-06-30 11:29 Tx date 2020-06-30 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
$16,800
+80,000 vol $0.21 each |
||
| Filed 2020-06-30 11:16 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-11 14:01 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 11:13 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 11:39 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+50,000 vol $0.40 each |
50,000 | |
| Filed 2019-08-02 11:36 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-02 11:13 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Warrant
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2019-08-02 11:00 Tx date 2019-08-02 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$15,000
+50,000 vol $0.30 each |
70,100 | |
| Filed 2019-02-07 Tx date 2019-02-07 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,112
+12,800 vol $0.79 each |
20,100 | |
| Filed 2019-02-07 Tx date 2018-08-20 |
$TBP
Tetra Bio-Pharma Inc. |
Néron, Steve
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,300 |